An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

Clinical trial NCT06693336 · RECRUITING

Trial details

NCT number: NCT06693336
Sponsor: ToLymph Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)

Start date: 2024-11-18
Primary completion: 2026-11-18
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.